JLE

Médecine de la Reproduction

MENU

Current issues about VIH and HTLV-1 infection and their treatment Volume 20, issue 2, Avril-Mai-Juin 2018

Figures


  • Figure 1

  • Figure 2

  • Figure 3

Tables

Authors
1 Service de maladies infectieuses et tropicales, hôpital Tenon AP-HP, Paris France
2 Service de virologie, hôpital Tenon AP-HP, Paris France
* Tirés à part

HIV (human immunodeficiency virus) and HTLV (human T lymphotropic virus) are zoonotic infections, due to transmission of retroviruses of simian origins to human people. Contamination routes share similarities for blood and sexual transmission, but mother-to-child transmission differs: mostly at the end of pregnancy, during childbirth or breastfeeding for HIV, prolonged breastfeeding for HTLV. The high seroprevalence for both viruses in West Africa and carribean regions contributes to the majority of HTLV infections found in France. Most of HIV-infected patients receive antiretroviral therapy to prevent transmission (in adults and mother to child transmission) and reduce immunodeficiency, whereas no specific treatment exists for HTLV infected patients. HTLV-associated diseases (leukemia/lymphoma or myeopathy) concerns less than 7 % of HTLV infected-patients and zidovudine, interferon or other immunotherapies are used for associated diseases such a as leukemia/lymphomia or myeolopathy.

Licence This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License